Johnson & Johnson
Jim Swanson is a global business and technology leader and Executive Vice President, Chief Information Officer, and member of the Executive Committee for Johnson & Johnson. Based at the company headquarters in New Jersey, Jim is responsible for accelerating Johnson & Johnson’s business outcomes and advancing human health with technology.
Jim joined Johnson & Johnson from Bayer Crop Science, a $20 billion division of Bayer, where he served as a member of the Executive Leadership Team and as CIO and Head of Digital Transformation. In this role, he inspired teams across the world to use digital innovation and data science to transform and deliver world-class products and services sustainably. Jim and the Information Technology organizations he has led have received industry accolades for their contributions in leadership, application of technology to deliver substantial business value, best places to work in IT, and support of STEM for emerging talent.
Previously, Jim served as CIO at Monsanto for five years before the company was acquired by Bayer. In addition, he had nine years of experience working as Vice President and CIO for Johnson & Johnson Pharmaceutical Research & Development, where he advanced technology throughout the company’s R&D organization.
He also amassed a breadth of experience at Merck, where he led the R&D and Commercial IT organizations, and SmithKline Beecham, where he was a bench scientist before transitioning to IT. During his career, Jim has had extensive international experience, including living in the UK and Germany.
Jim holds a bachelor's degree in Bioscience and Biotechnology and a master's degree in Computer Science, both from Drexel University.
Johnson & Johnson
528 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.